From: Reirradiation to the abdomen for gastrointestinal malignancies
Characteristic | Median (Range) or Number of Patients (%) |
---|---|
Age at Retreatment (years) | 56 (37-80) |
Gender | Â |
   Male | 9 (69%) |
   Female | 4 (31%) |
Pathology | Â |
   Pancreatic adenocarcinoma | 3 (23%) |
   Colon carcinoma | 3 (23%) |
   Cholangiocarcinoma | 2 (15%) |
   Others* | 5 (38%) |
Prior Radiotherapy Dose | Â |
   30 Gy (10-12 fractions) | 2 (15%) |
   35 Gy (14 fractions) | 2 (15%) |
   45 Gy (25 fractions) | 4 (31%) |
   50.4 Gy (28 fractions) | 5 (38%) |
Retreatment Interval (months) | 26 (5-83) |
Retreatment Dose** | Â |
   24 Gy | 1 (8%) |
   30 Gy | 6 (46%) |
   34.5 Gy | 1 (8%) |
   39 Gy | 4 (31%) |
   48 Gy | 1 (8%) |
Concurrent Chemotherapy | Â |
   Yes | 8 (62%) |
   No | 5 (38%) |
Indication for Retreatment | Â |
   Palliation of Pain | 5 (38%) |
   Palliation of Bleeding | 4 (31%) |
   Definitive (Not candidate for other treatments) | 3 (23%) |
   Consolidation after Chemotherapy | 1 (8%) |